News

Mirati Therapeutics To Present At The 2017 Jefferies Global Healthcare Conference

SAN DIEGO, May 31, 2017 /PRNewswire/ — Mirati Therapeutics, Inc. (MRTX), a clinical stage targeted oncology biotechnology company, will present at the 2017 Jefferies Global Healthcare Conference in New York on Wednesday, June 7th at 3:30 p.m. ET/ 12:30 p.m. PT. Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer will present a corporate overview.

2017-06-20T12:00:31+00:00